Literature DB >> 33992940

Ambient high temperature exposure and global disease burden during 1990-2019: An analysis of the Global Burden of Disease Study 2019.

Jian Song1, Rubing Pan1, Weizhuo Yi1, Qiannan Wei1, Wei Qin1, Shasha Song1, Chao Tang1, Yangyang He1, Xiangguo Liu1, Jian Cheng1, Hong Su2.   

Abstract

BACKGROUND: A warming climate throughout the 21st century makes ambient high temperature exposure a major threat to population health worldwide. Mitigating the health impact of high temperature requires a timely, comprehensive and reliable assessment of disease burden globally, regionally and temporally. AIM: Based on Global Burden of Disease (GBD) Study 2019, this study aimed to evaluate the disease burden attributable to high temperature from various epidemiology perspectives.
METHODS: A three-stage analysis was undertaken to investigate the number and age-standardized rates of death and disability-adjusted life years (DALY) attributable to high temperature from GBD Study 2019. First, we reported the high temperature-related disease burden for the whole world and for different groups by gender, age, region, country and disease. Second, we examined the temporal trend of the disease burden attributable to high temperature from 1990 to 2019. Finally, we explored if and how the high temperature-related disease burden was modified by a number of country-level indicators.
RESULTS: Globally, high temperature accounted for 0.54% of death and 0.46% of DALY in 2019, equating to the age-standardized rates of death and DALY (per 100,000 population) of 3.99 (95% uncertainty interval (UI): 2.88, 5.93) and 156.81 (95% UI: 107.98, 261.98), respectively. In 2019, the high temperature-related DALY and death rates were the highest for lower respiratory infections, although they showed a downward trend. In contrast, during 1990-2019, high temperature-related non-communicable diseases burden exhibited an upward trend. Meanwhile, the disease burden attributable to high temperature varied spatially, with the heaviest burden in regions with low sociodemographic index (SDI) and the lightest burden in regions with high SDI. In addition, high temperature-related disease burden appeared to be higher in a country with a higher population density and PM2.5 concentration background but lower in a country with a higher density of greenness.
CONCLUSION: This study for the first time provided a comprehensive understanding of the global disease burden attributable to high temperature, underscoring the policy priority to protect human health worldwide in the context of global warming with particular attention to vulnerable countries or regions as well as susceptible population and diseases.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Climate change; Global disease burden; High temperature

Year:  2021        PMID: 33992940     DOI: 10.1016/j.scitotenv.2021.147540

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  4 in total

Review 1.  Noncommunicable diseases, climate change and iniquities: What COVID-19 has taught us about syndemic.

Authors:  Agostino Di Ciaula; Marcin Krawczyk; Krzysztof J Filipiak; Andreas Geier; Leonilde Bonfrate; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2021-09-29       Impact factor: 4.686

2.  Changing trends in the air pollution-related disease burden from 1990 to 2019 and its predicted level in 25 years.

Authors:  Wan Hu; Lanlan Fang; Hengchuan Zhang; Ruyu Ni; Guixia Pan
Journal:  Environ Sci Pollut Res Int       Date:  2022-08-03       Impact factor: 5.190

Review 3.  Climate change and the prevention of cardiovascular disease.

Authors:  Alan P Jacobsen; Yii Chun Khiew; Eamon Duffy; James O'Connell; Evans Brown; Paul G Auwaerter; Roger S Blumenthal; Brian S Schwartz; John William McEvoy
Journal:  Am J Prev Cardiol       Date:  2022-09-11

Review 4.  Environmental health, COVID-19, and the syndemic: internal medicine facing the challenge.

Authors:  Agostino Di Ciaula; Hanns Moshammer; Paolo Lauriola; Piero Portincasa
Journal:  Intern Emerg Med       Date:  2022-10-01       Impact factor: 5.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.